AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Gregg Wallis

Gregg Wallis, PhD, CMgr.

Gregg Wallis is an R&D departmental manager for the Binding Site Group Ltd (Birmingham, UK), with responsibility for early-phase immunodiagnostic assay development and protein analysis. Prior to joining the Binding Site in 2004, Dr Wallis worked as a Senior Scientist for a French Biopharmaceutical company. Dr Wallis obtained a doctorate in Biochemistry from the Imperial College of science, technology & medicine (University of London) in 1993, and is a Chartered member of the Chartered Management Institute.